Pyroptosis-associated inflammasome activation contributes to scleral remodeling in experimental myopia

Ai-Lin Wang1, Qi Lyu2, Hong-Mei Wang3

  • 1Department of Ophthalmology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.

Abstract

Insights

Pyroptosis, an inflammatory cell death process, is involved in myopia development by weakening the sclera. Targeting the inflammasome-caspase-1-GSDMD pathway may help control myopia progression.

Area of Science:

  • Ophthalmology
  • Cell Biology
  • Immunology

Background:

  • Myopia is a prevalent vision disorder characterized by scleral remodeling.
  • The role of programmed cell death, specifically pyroptosis, in myopia pathogenesis is not well understood.

Purpose of the Study:

  • To investigate the involvement of pyroptosis in myopia initiation and progression.
  • To elucidate the regulatory role of pyroptosis in scleral remodeling.

Main Methods:

  • Transcriptome sequencing of scleral tissues from form-deprivation myopia (FDM) mouse models.
  • In vitro studies using human scleral fibroblasts treated with complement component 3a (C3a).
  • Analysis of pyroptosis markers (NLRP3, caspase-1, GSDMD-N), extracellular matrix (ECM) components, and inflammatory cytokines (IL-1β, IL-18).

Main Results:

  • Pyroptosis-related pathways and inflammasome signaling were significantly enriched in myopic scleral tissues.
  • In vitro models showed pyroptosis activation, increased inflammatory cytokines, and ECM degradation (decreased type I collagen, increased MMP-2).
  • Evidence of gasdermin protein-mediated cell membrane damage and pyroptotic morphology was observed.

Conclusions:

  • The inflammasome-caspase-1-GSDMD signaling axis is activated in myopia-related scleral remodeling.
  • Pyroptosis serves as a crucial link between inflammation and scleral weakening in myopia.
  • Targeting pyroptosis offers potential therapeutic strategies for myopia intervention.